• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前哨淋巴结活检后皮肤黑色素瘤复发的研究:播散模式及随访中补充检测的应用。

Study of cutaneous melanoma recurrences after sentinel node biopsy: Patterns of dissemination and use of complementary test in follow-up.

机构信息

Dermatology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.

Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.

出版信息

Eur J Cancer Care (Engl). 2021 Jan;30(1):e13344. doi: 10.1111/ecc.13344. Epub 2020 Oct 22.

DOI:10.1111/ecc.13344
PMID:33089896
Abstract

OBJECTIVES

To investigate the patterns of melanoma recurrence in the local population, including factors that may influence in this event and timing of relapse, and to determine the mode of detection of them.

METHODS

This is a retrospective cohort study of patients with melanoma who underwent sentinel lymph node biopsy at the Complejo Hospitalario de Navarra (Spain) from 2002 to 2012. The following data were collected of each patient: age, gender, date of diagnosis, location of melanoma, histological subtype, Breslow thickness, ulceration, mitosis, sentinel node status, AJCC 8th edition stage, site of first diagnosed metastasis, mode of relapse, date of first relapse and time of death.

RESULTS

Of 308 patients, 30% people suffered metastasis. The mean follow-up time was 68.63 months. 51.1% of relapses were locoregional and 48.9% haemato-visceral. Sentinel node status was the only variable associated with higher risk of haemato-visceral metastasis (p < 0.001). The mean time between diagnosis of melanoma and recurrence was 2.7 years. Most recurrences were detected by the patient himself or had any type of symptoms and were consequently selected for a complementary test.

CONCLUSION

It is important to follow-up all patients with diagnosis of cutaneous melanoma, essentially during the first 5 years after diagnosis.

摘要

目的

调查当地人群黑色素瘤复发的模式,包括可能影响该事件的因素和复发时间,并确定检测这些因素的方式。

方法

这是一项对 2002 年至 2012 年间在纳瓦拉综合医院(西班牙)接受前哨淋巴结活检的黑色素瘤患者进行的回顾性队列研究。收集每位患者的以下数据:年龄、性别、诊断日期、黑色素瘤位置、组织学亚型、Breslow 厚度、溃疡、有丝分裂、前哨淋巴结状态、第 8 版 AJCC 分期、首次诊断转移部位、复发模式、首次复发日期和死亡日期。

结果

在 308 名患者中,有 30%的人发生了转移。平均随访时间为 68.63 个月。51.1%的复发为局部区域复发,48.9%为血液-内脏转移。前哨淋巴结状态是唯一与更高风险的血液-内脏转移相关的变量(p<0.001)。从黑色素瘤诊断到复发的平均时间为 2.7 年。大多数复发是由患者自己发现或出现任何类型的症状,并因此选择进行补充检查。

结论

对所有诊断为皮肤黑色素瘤的患者进行随访非常重要,尤其是在诊断后的前 5 年内。

相似文献

1
Study of cutaneous melanoma recurrences after sentinel node biopsy: Patterns of dissemination and use of complementary test in follow-up.前哨淋巴结活检后皮肤黑色素瘤复发的研究:播散模式及随访中补充检测的应用。
Eur J Cancer Care (Engl). 2021 Jan;30(1):e13344. doi: 10.1111/ecc.13344. Epub 2020 Oct 22.
2
Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.黑色素瘤前哨淋巴结活检及选择性淋巴结清扫术后的初始复发模式及预后
Plast Reconstr Surg. 2003 Aug;112(2):486-97. doi: 10.1097/01.PRS.0000070989.23469.1F.
3
Sentinel node tumor burden in cutaneous melanoma. Survival with competing risk analysis and influence in relapses and non-sentinel node status: retrospective cohort study with long follow-up in a Spanish population.皮肤黑色素瘤中的前哨淋巴结肿瘤负荷。采用竞争风险分析的生存分析及其对复发和非前哨淋巴结状态的影响:在西班牙人群中进行的长期随访回顾性队列研究。
Arch Dermatol Res. 2022 May;314(4):369-378. doi: 10.1007/s00403-021-02232-z. Epub 2021 May 10.
4
Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.黑色素瘤患者前哨淋巴结手术后首个复发部位的模式及发生率
World J Surg. 2002 Dec;26(12):1405-11. doi: 10.1007/s00268-002-6197-8. Epub 2002 Sep 26.
5
Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases.单机构治疗临床I期和II期皮肤黑色素瘤患者的经验:240例前哨淋巴结活检结果
Dermatol Surg. 2005 Nov;31(11 Pt 1):1385-93. doi: 10.2310/6350.2005.31202.
6
[Sentinel lymph node biopsy in melanoma: our experience over 8 years in a universitary hospital].[黑色素瘤前哨淋巴结活检:我们在一家大学医院8年的经验]
Cir Cir. 2015 Sep-Oct;83(5):378-85. doi: 10.1016/j.circir.2015.05.032. Epub 2015 Jun 30.
7
Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor.高危原发性肿瘤诊断后黑色素瘤复发的风险。
JAMA Dermatol. 2019 Jun 1;155(6):688-693. doi: 10.1001/jamadermatol.2019.0440.
8
The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy.厚度小于1.0毫米的黑色素瘤患者区域淋巴结转移的风险:前哨淋巴结活检的建议
J Am Coll Surg. 2003 Sep;197(3):403-7. doi: 10.1016/S1072-7515(03)00432-0.
9
Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?T1期(薄型)黑色素瘤的前哨淋巴结活检:有必要吗?
Ann Plast Surg. 2003 Jun;50(6):601-6. doi: 10.1097/01.SAP.0000069065.00486.1E.
10
Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.前哨淋巴结活检在厚型恶性黑色素瘤中的应用:10 年单中心经验。
J Plast Reconstr Aesthet Surg. 2012 Oct;65(10):1396-402. doi: 10.1016/j.bjps.2012.04.019. Epub 2012 May 1.

引用本文的文献

1
Clinical, humanistic and economic burden associated with recurrence among patients with early-stage cancers: a systematic literature review.早期癌症患者复发相关的临床、人文和经济负担:一项系统文献综述
Front Oncol. 2025 May 26;15:1575813. doi: 10.3389/fonc.2025.1575813. eCollection 2025.
2
Individualized Prediction for Risk of Recurrence in Stage I/II Melanoma Patients With Negative Sentinel Lymph Node.Ⅰ/Ⅱ期黑色素瘤患者前哨淋巴结阴性时复发风险的个体化预测。
Cancer Med. 2024 Dec;13(23):e70441. doi: 10.1002/cam4.70441.